UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.168

Sortiert nach

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer

Cancer cell, 2016-10, Vol.30 (4), p.637-650

2016

Volltextzugriff (PDF)

Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local

Frontiers in immunology, 2018-06, Vol.9, p.1305-1305

2018

Volltextzugriff (PDF)

Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics

Molecules (Basel, Switzerland), 2019-08, Vol.24 (17), p.3121

2019

Volltextzugriff (PDF)

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Journal of experimental & clinical cancer research, 2022-06, Vol.41 (1), p.186-186, Article 186

2022

Volltextzugriff (PDF)

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway

BMC cancer, 2019-05, Vol.19 (1), p.485-12, Article 485

2019

Volltextzugriff (PDF)

A novel XBP1 variant is highly enriched in cancer tissues and is specifically required for cancer cell survival

Biochemical and biophysical research communications, 2021-07, Vol.562, p.69-75

2021

Volltextzugriff (PDF)

Breaking Mitochondrial Fasting for Cancer Treatment: Old Wine in New Bottles

JNCI : Journal of the National Cancer Institute, 2017-11, Vol.109 (11)

2017

Volltextzugriff (PDF)

Dual targeting of glutamine and serine metabolism in acute myeloid leukemia

Frontiers in oncology, 2024-04, Vol.14, p.1326754-1326754

2024

Volltextzugriff (PDF)

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Clinical cancer research, 2022-04, Vol.28 (7), p.1313-1322

2022

Volltextzugriff (PDF)

Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency

Proceedings of the National Academy of Sciences - PNAS, 2020-07, Vol.117 (30), p.17785-17795

2020

Volltextzugriff (PDF)

A Randomized Assessment of a Laxative-Based Clostridioides difficile Diagnostic Stewardship Intervention

Infection control and hospital epidemiology, 2020-10, Vol.41 (S1), p.s102-s103

2020

Volltextzugriff (PDF)

PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation

Molecular cancer therapeutics, 2021-04, Vol.20 (4), p.676-690

2021

Volltextzugriff (PDF)

Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors

Physics in medicine & biology, 2020-06, Vol.65 (12), p.125017-125017

2020

Volltextzugriff (PDF)

Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system

Bioorganic & medicinal chemistry, 2016-06, Vol.24 (12), p.2595-2602

2016

Volltextzugriff (PDF)

Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma

Oral oncology, 2022-08, Vol.131, p.105939-105939, Article 105939

2022

Volltextzugriff (PDF)

SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma

Scientific reports, 2020-12, Vol.10 (1), p.21159, Article 21159

2020

Volltextzugriff (PDF)

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

Proceedings of the National Academy of Sciences - PNAS, 2022-07, Vol.119 (28), p.e2201423119-e2201423119

2022

Volltextzugriff (PDF)

Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax

Experimental hematology, 2022-04, Vol.108, p.55-63

2022

Volltextzugriff (PDF)

Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity

Oncotarget, 2017-09, Vol.8 (41), p.70916-70940

2017

Volltextzugriff (PDF)

Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice

Cancer research (Chicago, Ill.), 2011-06, Vol.71 (11), p.3952-3962

2011

Volltextzugriff (PDF)

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias

Cancer chemotherapy and pharmacology, 2013-10, Vol.72 (4), p.897-908

2013

Volltextzugriff (PDF)

Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA

Molecular cancer therapeutics, 2016-07, Vol.15 (7), p.1504-1514

2016

Volltextzugriff (PDF)

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine

Frontiers in oncology, 2022-12, Vol.12, p.1035537-1035537

2022

Volltextzugriff (PDF)

Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation

Clinical cancer research, 2018-01, Vol.24 (1), p.234-247

2018

Volltextzugriff (PDF)

1 – 25 von 1.168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.044)
Mit Volltextzugriff
(1.052)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer

Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local

Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway

A novel XBP1 variant is highly enriched in cancer tissues and is specifically required for cancer cell survival

Breaking Mitochondrial Fasting for Cancer Treatment: Old Wine in New Bottles

Dual targeting of glutamine and serine metabolism in acute myeloid leukemia

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency

A Randomized Assessment of a Laxative-Based Clostridioides difficile Diagnostic Stewardship Intervention

PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation

Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors

Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system

Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma

SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer

Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax

Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity

Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias

Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine

Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation

Suchergebnisse filtern